Study details including sample sizes, participant demographics and population sources
| Paper | Sample size | Gender (F:M) | Age range (mean age) | Height (m), weight (kg) | ||||
|---|---|---|---|---|---|---|---|---|
| PFPS | CON | PFPS | CON | PFPS | CON | PFPS | CON | |
| Aminaka et al36 | 20 | 20 | 13 : 7 | 13 : 7 | NR (21±4) | NR (21±4) | 1.70±0.10, 71±15 | 1.72±0.09, 70±10 |
| Brindle et al39 | 16 | 12 | 12 : 4 | 7 : 5 | 18–35 (NR) | 18–35 | NR, NR | NR, NR |
| Boling et al34 | 14 | 14 | 9 : 5 | 9 : 5 | 18–42 (24±6) | 18–42 (23±2) | 1.68±0.10, 72±12 | 1.71±0.07, 72±16 |
| Cowan et al32 | 10 | 27 | 7 : 3 | 15 : 12 | 18–40 (26±10) | 18–40 (25±6) | 1.72±0.04, 63±8 | 1.90±0.09, 69±9 |
| Earl et al33 | 16 | 16 | 13 : 3 | 13 : 3 | NR (22±4) | NR (21±6) | 1.65±0.10, 62±13 | 1.66±0.12, 65±14 |
| Nakagawa et al38 | 9 | 10 | 9 : 0 | 10 : 0 | 18–35 (23±5) | 18–35 (23±2) | 1.65±0.07, 61±10 | 1.63±0.06, 56±4 |
| Ott et al40 | 20* | 20 | NR | NR | 18–45 (21±NR) | 18–45 (23±4) | 1.71±0.07, 70±8 | 1.68±0.07, 77±7 |
| Saad et al37 | 15 | 15 | NR | NR | NR (23±2) | NR (23±2) | 1.60±3, 59±4 | 1.60±3, 53±2 |
| Souza and Powers35 | 21 | 20 | 21 : 0 | 20 : 0 | 18–45 (27±6) | 18–45 (26±5) | 1.70±0.06, 65±10 | 1.70±0.05, 63±7 |
| Willson et al31 | 20 | 20 | 20 : 0 | 20 : 0 | 18–35 (21±3) | 18–35 (22±5) | 1.68±0.06, 63±8 | 1.69±0.09, 62±9 |
*Comprised of two groups; (1) low pain≤1.4 cm increase in pain visual analogue scale following aerobic exercise, n=9 and (2) high pain≥1.4 cm increase in pain visual analogue scale following aerobic exercise, n=11.
CON, control; F, female; M, male; NR, not reported; PFPS, patellofemoral pain syndrome.